相关实验视频

Updated: Sep 14, 2025

Establishing a Mouse Model of Thin Endometrium

Establishing a Mouse Model of Thin Endometrium

Published on: November 1, 2024

降低IGFBP2的调节会调节子宫内膜上皮细胞在子宫内膜薄膜中的衰老

Zihan Zhou¹, Zhenhua Zhou¹, Chunying Ye²

¹Department of Obstetrics and Gynecology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China.

Molecular human reproduction

|July 23, 2025

概括

胰岛素样生长因子结合蛋白2 (IGFBP2) 的降低导致子宫内膜上皮细胞在薄型子宫内膜 (TE) 中衰老. 恢复IGFBP2缓解衰老并改善子宫内膜厚度,为TE提供新的治疗点.

科学领域:

生殖生物学生殖生物学
细胞衰老细胞衰老
分子内分泌学分子内分泌学

背景情况:

薄子宫内膜 (TE) 与减少怀孕率和不良周产期结果有关.
TE病变的潜在机制在很大程度上是未知的.
子宫内膜上皮细胞中的细胞衰老与TE有关.

研究的目的:

调查胰岛素类生长因子结合蛋白2 (IGFBP2) 在TE病变发生过程中的作用.
探索IGFBP2作为TE的潜在治疗点.

主要方法:

来自TE患者的单细胞RNA测序数据的分析.
在体外实验中使用人类子宫内膜上皮细胞和石川细胞 (IKC).
在体内研究中,使用TE小鼠模型诱导子宫内膜切和H2O2灌注.

主要成果:

在TE中发现了IGFBP2的下调,导致子宫内膜上皮细胞衰老.
再组合的人类IGFBP2蛋白治疗在体外减轻了过氧化 (H2O2) 诱导的衰老,在某些方面表现优于达沙替尼.
通过IGFBP2 siRNA转染促进了通过PI3K/AKT/PTEN通路的P21积累.
在TE小鼠模型中,IGFBP2蛋白或达萨提尼布的使用通过抑制衰老恢复了子宫内膜厚度.

结论:

下调的IGFBP2是介导TE内子宫内皮细胞衰老的关键因素.
IGFBP2在维持子宫内膜健康和厚度方面发挥着至关重要的作用.
IGFBP2代表了治疗TE的有前途的新疗法标.

关键词:

达沙替尼布 (Dasatinib) 是一种在IGFBP2中使用.这就是PI3KAKTT.在子宫内膜上皮细胞.衰老是一种老化.一个薄的子宫内膜.

更多相关视频

Two Methods for Establishing Primary Human Endometrial Stromal Cells from Hysterectomy Specimens

Two Methods for Establishing Primary Human Endometrial Stromal Cells from Hysterectomy Specimens

Published on: May 23, 2014

Establishing 3D Endometrial Organoids from the Mouse Uterus

Establishing 3D Endometrial Organoids from the Mouse Uterus

Published on: January 6, 2023

相关概念视频

Receptor Downregulation in MVBs

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...

Hormonal Regulation of the Menstrual Cycle

Hormonal Regulation of the Menstrual Cycle

The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...

Proliferative Phase

Proliferative Phase

The proliferative phase typically occurs after menstruation and lasts between 6 to 13 days in a standard 28-day cycle. This phase involves the reconstruction of the endometrium, guided by estrogen produced by the developing ovarian follicle.
Notably, the stratum basale, the basal layer of the endometrium, including the basal parts of the uterine glands, remains unaffected by menstruation. Stem cells in this layer undergo mitosis, regenerating the stratum functionalis and thickening the...

Replicative Cell Senescence

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...

TGF - β Signaling Pathway

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...

Ovarian Cycle

Ovarian Cycle

The menstrual cycle includes a critical component known as the ovarian cycle, which undergoes two main phases each month—the follicular phase and the luteal phase. The follicular phase is variable and averaging around 14 days. Ovulation, triggered by a surge in luteinizing hormone (LH), marks the transition between the two phases. The second phase, the luteal phase, is relatively consistent, lasting approximately 14 days, and is marked by the activity of the corpus luteum. While a cycle...